Why beetroot works for a few weeks, then stops. And what the research points to next.

For three weeks, the beetroot worked. The morning readings looked better than they had in months. The routine felt worth it. Then somewhere around the first month the effect faded, and it never fully came back.

If that pattern sounds familiar, you are not imagining it, and you did not buy a bad product. The same story shows up again and again wherever people compare notes on blood pressure. A strong start. Real improvement. Then a slow slide back to where they began. To understand why, you have to look at what beetroot actually does inside a blood vessel.

What beetroot is really doing

Beetroot is rich in dietary nitrates. Your body converts them into nitric oxide, a molecule that signals the smooth muscle in your vessel walls to relax. When the vessel relaxes, it widens, blood moves more easily, and pressure eases. That part is real. It is well studied, and it is why the first few weeks feel like an answer.

But notice what that mechanism is. It is relaxation, and relaxation is temporary by design. Nitric oxide works while the dose is in your system and lets go the moment it clears. Beetroot was always doing a short-term job. The early weeks were the honeymoon, not the cure.

The problem beetroot was never built to touch

The reason a vessel narrows in the first place is not that it forgot how to relax. It is that material has accumulated inside the artery wall. That buildup is held together by a sticky protein called fibrin.

No amount of relaxing the vessel breaks fibrin down. You can widen the opening for a few hours at a time, but the structure inside the wall is still there when the dose clears. That is the mechanical reason the beetroot effect keeps reversing. It is working on tone, not on structure.

So we looked into what the research points to for the structural side of the problem. One name came up repeatedly, and it works through a completely different mechanism.

A different mechanism: working on the buildup itself

Nattokinase is an enzyme drawn from a traditional Japanese food called natto. Unlike nitric oxide, it is not a vasodilator. It is fibrinolytic, which means it works on fibrin, the protein holding the buildup together.

In a randomized study, Ren and colleagues (2017) reported roughly a 36% reduction in arterial buildup over 26 weeks of daily nattokinase. A larger and longer review tells a complementary story. In a 2022 study published in Frontiers in Cardiovascular Medicine, a retrospective observational look at over a thousand people taking 10,800 FU daily for a year, nattokinase was associated with healthier blood pressure and improved cholesterol.

And here is the part that connects back to your readings. That same research found the blood pressure and cholesterol improvements followed from the buildup coming down. As the buildup clears, the artery opens, so the heart pushes against less resistance and pressure eases. The cholesterol that was trapped inside that buildup gets freed for the body to clear, instead of staying locked in the wall. The numbers moved because the structure holding them moved first.

That is the difference in one sentence. Beetroot widens the vessel for a few hours. Nattokinase is studied for working on what has collected inside it over years.

Why the dose is the whole story

There is one detail you cannot skip, because it is where most people go wrong even after they switch.

The 2022 research used 10,800 FU of enzyme activity per day. FU stands for fibrinolytic units, and it measures how much of the enzyme is actually working, which is not the same as the milligram weight printed on most labels. In that same study, a lower 3,600 FU dose produced no significant improvement. The dose was not a detail. It was the whole result.

This matters because the typical nattokinase product on a pharmacy shelf lands near 2,000 FU, well below the level the research used. A product that does not reach the researched activity is not a smaller version of the same thing. In the study, it was a different outcome entirely.

1. The researched dose. Does a daily serving reach 10,800 FU, the activity level the human research used? Not milligrams. Fibrinolytic units.
2. Verified activity. Does an independent lab confirm that FU, rather than the label simply asserting it? A number you cannot check is a claim, not a fact.
3. Enteric coating. Stomach acid destroys unprotected nattokinase before absorption. Without an enteric coat, the activity on the label barely survives the trip.

The product built around that mechanism

Of the options we looked at, the one built specifically around this mechanism, at this dose, is Hale Heart. It delivers 10,000 FU of nattokinase daily, the exact activity level the human research used. It is enteric coated so the enzyme survives the stomach. And its activity is verified by independent lab testing rather than asserted on the label.

If beetroot gave you a few good weeks and then drifted back, this is the structural side of the same problem, approached through the mechanism beetroot was never able to reach.

Before you start: what to discuss with your doctor

Nattokinase affects the way blood breaks down fibrin, so a few situations call for a conversation with your physician first.

• If you take a blood thinner or anticoagulant medication.
• If you have a bleeding disorder.
• If you have surgery or a dental procedure scheduled.
• Nattokinase is not a replacement for a prescribed statin or blood pressure medication. Do not stop or change a prescription without medical guidance. Beetroot is not a treatment for any condition either, and stopping it is not a medical decision to make alone.

About this review. The American Association of Cardiology Research Digest is an editorial publication. Mechanisms and findings described here are drawn from published nattokinase and dietary-nitrate research. Statements about supplements have not been evaluated by the Food and Drug Administration. This content is for general education and is not medical advice.